Impaired functional recovery of endothelial colony-forming cells from moyamoya disease in a chronic cerebral hypoperfusion rat model
- PMID: 30668528
- DOI: 10.3171/2018.8.PEDS1883
Impaired functional recovery of endothelial colony-forming cells from moyamoya disease in a chronic cerebral hypoperfusion rat model
Abstract
OBJECTIVEEndothelial colony-forming cells (ECFCs) isolated from pediatric patients with moyamoya disease (MMD) have demonstrated decreased numbers and defective functioning in in vitro experiments. However, the function of ECFCs has not been evaluated using in vivo animal models. In this study, the authors compared normal and MMD ECFCs using a chronic cerebral hypoperfusion (CCH) rat model.METHODSA CCH rat model was made via ligation of the bilateral common carotid arteries (2-vessel occlusion [2-VO]). The rats were divided into three experimental groups: vehicle-treated (n = 8), normal ECFC-treated (n = 8), and MMD ECFC-treated (n = 8). ECFCs were injected into the cisterna magna. A laser Doppler flowmeter was used to evaluate cerebral blood flow, and a radial arm maze test was used to examine cognitive function. Neuropathological examinations of the hippocampus and agranular cortex were performed using hematoxylin and eosin and Luxol fast blue staining in addition to immunofluorescence with CD31, von Willebrand factor, NeuN, myelin basic protein, glial fibrillary acidic protein, and cleaved caspase-3 antibodies.RESULTSThe normal ECFC-treated group exhibited improvement in the restoration of cerebral perfusion and in behavior compared with the vehicle-treated and MMD ECFC-treated groups at the 12-week follow-up after the 2-VO surgery. The normal ECFC-treated group showed a greater amount of neovasculogenesis and neurogenesis, with less apoptosis, than the other groups.CONCLUSIONSThese results support the impaired functional recovery of MMD ECFCs compared with normal ECFCs in a CCH rat model. This in vivo study suggests the functional role of ECFCs in the pathogenesis of MMD.
Keywords: 2-VO = 2-vessel occlusion; CBF = cerebral blood flow; CCH = chronic cerebral hypoperfusion; ECFC = endothelial colony-forming cell; GFAP = glial fibrillary acidic protein; LDF = laser Doppler flowmeter; LDL = low-density lipoprotein; LFB = Luxol fast blue; MBP = myelin basic protein; MCA = middle cerebral artery; MCAO = MCA occlusion; MMD = moyamoya disease; RAM = radial arm maze; SMPC = smooth muscle progenitor cell; chronic cerebral hypoperfusion; endothelial colony-forming cells; moyamoya disease; rat model; vWf = von Willebrand factor; vascular disorders.
Similar articles
-
A refined model of chronic cerebral hypoperfusion resulting in cognitive impairment and a low mortality rate in rats.J Neurosurg. 2018 Sep 7;131(3):892-902. doi: 10.3171/2018.3.JNS172274. J Neurosurg. 2018. PMID: 30192196
-
Chemokine Ligand 5 (CCL5) Derived from Endothelial Colony-Forming Cells (ECFCs) Mediates Recruitment of Smooth Muscle Progenitor Cells (SPCs) toward Critical Vascular Locations in Moyamoya Disease.PLoS One. 2017 Jan 10;12(1):e0169714. doi: 10.1371/journal.pone.0169714. eCollection 2017. PLoS One. 2017. PMID: 28072843 Free PMC article.
-
Panobinostat, a histone deacetylase inhibitor, rescues the angiogenic potential of endothelial colony-forming cells in moyamoya disease.Childs Nerv Syst. 2019 May;35(5):823-831. doi: 10.1007/s00381-019-04099-y. Epub 2019 Feb 27. Childs Nerv Syst. 2019. PMID: 30815722
-
Moyamoya disease: a summary.Neurosurg Focus. 2009 Apr;26(4):E11. doi: 10.3171/2009.1.FOCUS08310. Neurosurg Focus. 2009. PMID: 19335127 Review.
-
Experimental animal models for moyamoya disease and treatment: a pathogenesis-oriented scoping review.Neurosurg Focus. 2021 Sep;51(3):E5. doi: 10.3171/2021.6.FOCUS21284. Neurosurg Focus. 2021. PMID: 34469865 Review.
Cited by
-
Dexmedetomidine Stereotaxic Injection Alleviates Neuronal Loss Following Bilateral Common Carotid Artery Occlusion via Up-Regulation of BDNF Expression.In Vivo. 2024 Jan-Feb;38(1):184-189. doi: 10.21873/invivo.13424. In Vivo. 2024. PMID: 38148065 Free PMC article.
-
Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases.Front Neurol. 2023 May 16;14:661611. doi: 10.3389/fneur.2023.661611. eCollection 2023. Front Neurol. 2023. PMID: 37273690 Free PMC article. Review.
-
Cyclin-Dependent Kinase Inhibitor 2A is a Key Regulator of Cell Cycle Arrest and Senescence in Endothelial Colony-Forming Cells in Moyamoya Disease.J Korean Neurosurg Soc. 2023 Nov;66(6):642-651. doi: 10.3340/jkns.2023.0005. Epub 2023 May 4. J Korean Neurosurg Soc. 2023. PMID: 37138505 Free PMC article.
-
Increase of Circulating Endothelial Progenitor Cells and Released Angiogenic Factors in Children with Moyamoya Arteriopathy.Int J Mol Sci. 2023 Jan 8;24(2):1233. doi: 10.3390/ijms24021233. Int J Mol Sci. 2023. PMID: 36674749 Free PMC article.
-
Higher Circulating Trimethylamine N-Oxide Aggravates Cognitive Impairment Probably via Downregulating Hippocampal SIRT1 in Vascular Dementia Rats.Cells. 2022 Nov 17;11(22):3650. doi: 10.3390/cells11223650. Cells. 2022. PMID: 36429082 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
